Thank you for contacting us! We will be in touch soon! In the meantime, feel free to continue browsing our site.
Events
- AACR 2024: Apr 7-10 | March 26, 2024
- BIO-Europe Spring 2024 | Schedule 1-on-1 Meetings with Biocytogen | March 14, 2024
- Join us at World ADC London 2024: Mar 13-14 | March 08, 2024
- Join us at SAPA-GP Annual Conference 2024: Mar 8-9 | March 01, 2024
- Webinar: Translational Animal Models of Atopic Dermatitis (AD) for Preclinical Studies | February 28, 2024
- Webinar: Preclinical Pharmacology Services to Support Evaluation of Novel Cell & Gene Therapies | January 30, 2024
News
- Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates | March 25, 2024
- Mar 2024 Newsletter | March 10, 2024
- Biocytogen Symposium 2024: New Targets, New Therapeutics | February 24, 2024
- Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement | February 20, 2024
- Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development | January 23, 2024
- Dr. Yuelei Shen Shared His Insights During Investment Reports/Newsweek Interview | January 19, 2024